Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice

Angélica Maria Sabogal-Guáqueta1, Edison Osorio2, Gloria Patricia Cardona-Gómez1

  • 1Neuroscience Group of Antioquia, Cellular and Molecular Neurobiology Area - School of Medicine, SIU, University of Antioquia UdeA, Calle 70 No, 52-21, Medellin, Colombia.

Neuropharmacology
|November 10, 2015
PubMed

Insights

Linalool, a natural compound, improved cognitive and emotional functions in a mouse model of Alzheimer's disease (AD). It reduced key AD hallmarks and inflammation, suggesting potential for AD prevention.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with limited treatment options.
  • Research is focusing on lifestyle, diet, and natural products for AD prevention and treatment.
  • Natural products offer a promising avenue for managing age-related cognitive decline.

Purpose of the Study:

  • To investigate the therapeutic potential of linalool in an Alzheimer's disease mouse model.
  • To evaluate the effects of linalool on cognitive function, memory, and emotional behavior.
  • To examine the impact of linalool on AD-related neuropathology and neuroinflammation.

Main Methods:

  • Oral administration of linalool (25 mg/kg) every 48 hours for 3 months to aged triple transgenic AD mice (3xTg-AD).
  • Assessment of learning, spatial memory, and risk assessment behavior using behavioral tests (e.g., elevated plus maze).
  • Histopathological analysis of brain tissues (hippocampi and amygdalae) for amyloid-beta, tauopathy, astrogliosis, and microgliosis.

Main Results:

  • Linalool treatment significantly improved learning, spatial memory, and risk assessment in 3xTg-AD mice.
  • Reduced levels of extracellular beta-amyloidosis, tauopathy, astrogliosis, and microgliosis were observed in the brains of treated mice.
  • Linalool administration led to a significant decrease in pro-inflammatory markers, including p38 MAPK, NOS2, COX2, and IL-1β.

Conclusions:

  • Linalool effectively reverses key histopathological hallmarks of Alzheimer's disease in a mouse model.
  • The compound restores cognitive and emotional functions, likely through its anti-inflammatory effects.
  • Linalool shows promise as a potential candidate for Alzheimer's disease prevention in preclinical studies.

Related Concept Videos